Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David H Fitchett

Showing results (1-10 of 54) with videos related to

Pageof 6
Sort By:
European Endocrinology|October 24, 2018
Empagliflozin and Cardio-renal Outcomes in Patients with Type 2 Diabetes and Cardiovascular Disease - Implications for Clinical PracticeDavid H Fitchett
The Canadian Journal of Cardiology|November 29, 2011
Acute coronary syndromes: a Canadian perspectiveDavid H Fitchett
Future Cardiology|October 7, 2009
Future strategies for improving outcomes in patients with diabetes and acute coronary syndromesDavid H Fitchett
Drug Design, Development and Therapy|December 5, 2012
Potential role of rivaroxaban in patients with acute coronary syndromeDavid H Fitchett
The Canadian Journal of Cardiology|September 13, 2008
Ischemic stroke: a cardiovascular risk equivalent? Lessons learned from the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trialDavid H Fitchett, Shaun G Goodman, Anatoly Langer
Circulation|April 1, 2015
Cardiology patient page. Statin intoleranceDavid H Fitchett, Robert A Hegele, Subodh Verma
Canadian Journal of Diabetes|September 28, 2013
Management of acute coronary syndromes, Jean-Claude Tardif, Phillipe L L'Allier, et al.
The Canadian Journal of Cardiology|June 19, 2009
Acute coronary thrombosis in a patient with diabetes and severe hyperglycemiaJason D Roberts, Gavin Y Oudit, David H Fitchett
European Journal of Heart Failure|September 23, 2016
Heart failure outcomes in clinical trials of glucose-lowering agents in patients with diabetesDavid H Fitchett, Jacob A Udell, Silvio E Inzucchi
Canadian Journal of Diabetes|April 14, 2018
Management of Acute Coronary Syndromes, Jean-Claude Tardif, Phillipe L L'Allier, et al.
Pageof 6

Showing results (1-10 of 54) with videos related to

Sort By:
Pageof 6
European Endocrinology|October 24, 2018
Empagliflozin and Cardio-renal Outcomes in Patients with Type 2 Diabetes and Cardiovascular Disease - Implications for Clinical PracticeDavid H Fitchett
The Canadian Journal of Cardiology|November 29, 2011
Acute coronary syndromes: a Canadian perspectiveDavid H Fitchett
Future Cardiology|October 7, 2009
Future strategies for improving outcomes in patients with diabetes and acute coronary syndromesDavid H Fitchett
Drug Design, Development and Therapy|December 5, 2012
Potential role of rivaroxaban in patients with acute coronary syndromeDavid H Fitchett
The Canadian Journal of Cardiology|September 13, 2008
Ischemic stroke: a cardiovascular risk equivalent? Lessons learned from the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trialDavid H Fitchett, Shaun G Goodman, Anatoly Langer
Circulation|April 1, 2015
Cardiology patient page. Statin intoleranceDavid H Fitchett, Robert A Hegele, Subodh Verma
Canadian Journal of Diabetes|September 28, 2013
Management of acute coronary syndromes, Jean-Claude Tardif, Phillipe L L'Allier, et al.
The Canadian Journal of Cardiology|June 19, 2009
Acute coronary thrombosis in a patient with diabetes and severe hyperglycemiaJason D Roberts, Gavin Y Oudit, David H Fitchett
European Journal of Heart Failure|September 23, 2016
Heart failure outcomes in clinical trials of glucose-lowering agents in patients with diabetesDavid H Fitchett, Jacob A Udell, Silvio E Inzucchi
Canadian Journal of Diabetes|April 14, 2018
Management of Acute Coronary Syndromes, Jean-Claude Tardif, Phillipe L L'Allier, et al.
Pageof 6